Published in Vasc Health Risk Manag on August 26, 2011
Bleeding risk stratification in an era of aggressive management of acute coronary syndromes. World J Cardiol (2014) 0.76
Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China. Exp Ther Med (2016) 0.75
The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis. Thromb Res (2016) 0.75
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med (1993) 11.11
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (2011) 8.49
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med (2008) 5.86
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA (2006) 5.74
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49
Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med (2006) 5.24
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 3.72
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J (2008) 3.38
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation (2006) 3.22
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet (2009) 2.82
A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol (2010) 2.62
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol (2008) 2.38
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation (2005) 2.24
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J (2003) 2.20
Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol (2003) 2.18
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol (2007) 2.14
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation (2007) 2.12
Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol (2008) 2.05
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol (2005) 1.96
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol (2007) 1.75
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J (2008) 1.65
Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention. Am Heart J (2010) 1.65
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol (2007) 1.59
The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol (2005) 1.39
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J (2007) 1.37
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol (2006) 1.37
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J (2011) 1.34
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J (2009) 1.21
Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol (2011) 1.20
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol (2004) 1.06
Duration of red cell storage before transfusion and in-hospital mortality. Am Heart J (2010) 1.06
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. J Am Coll Cardiol (2011) 1.01
Is old blood bad blood? Am Heart J (2010) 0.95
The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk. J Invasive Cardiol (2010) 0.83
Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Drug Des Devel Ther (2010) 0.81
Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies. Am J Cardiol (2009) 0.77
Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes. Cleve Clin J Med (2010) 0.76
Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol (2007) 1.90
Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol (2008) 1.65
Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry (2010) 1.33
New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes (2011) 1.13
Can new-onset diabetes after kidney transplant be prevented? Diabetes Care (2013) 1.10
Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database. Transplantation (2010) 1.03
Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS database. Transplantation (2008) 0.99
BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions. Curr Opin Organ Transplant (2014) 0.88
Changes in the small bowel of symptomatic kidney transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. Am J Nephrol (2014) 0.85
The case of the missed physical examination: testicular carcinoma presenting as a GI bleed. J Clin Oncol (2013) 0.85
Evaluation of adult kidney transplant candidates. Semin Dial (2010) 0.84
Using the theory of planned behavior to explain the drinking motivations of social, high-risk, and extreme drinkers on game day. J Community Health (2010) 0.84
Polyclonal antibody-induced serum sickness presenting as rapidly progressive descending paralysis. Transplantation (2007) 0.84
Lithium induces c-Ret expression in mouse inner medullary collecting duct cells. Cell Signal (2010) 0.83
Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI. Front Psychiatry (2013) 0.83
Neural responses to incongruency in a blocked-trial Stroop fMRI task in major depressive disorder. J Affect Disord (2012) 0.82
Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Drug Des Devel Ther (2010) 0.81
ABO blood type-incompatible kidney transplantation and access to organs. Arch Surg (2011) 0.81
Acute coronary syndrome in patients with diabetes mellitus: perspectives of an interventional cardiologist. Am J Cardiol (2012) 0.81
Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation (2007) 0.81
Kidney dysfunction in the recipients of liver transplants. Liver Transpl (2005) 0.80
Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes. Clin Diabetes (2014) 0.79
Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrol Dial Transplant (2013) 0.79
Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database. Transplantation (2010) 0.79
Assessing the risk of post-transplantation diabetes mellitus with an oral glucose tolerance test. Nat Clin Pract Nephrol (2008) 0.79
Immunosuppressive management of dialysis patients with recently failed transplants. Semin Dial (2011) 0.77
Response to Comment on: Chakkera et al. Can New-Onset Diabetes After Kidney Transplant Be Prevented? Diabetes Care 2013;36:1406-1412. Diabetes Care (2013) 0.77
Efficacy of CPC and essential oils mouthwashes compared to a negative control mouthwash in controlling established dental plaque and gingivitis: A 6-week, randomized clinical trial. Am J Dent (2015) 0.76
Hypertonicity increases CLC-5 expression in mouse medullary thick ascending limb cells. Am J Physiol Renal Physiol (2004) 0.76
Thrombotic microangiopathy following pancreas after kidney transplants. Clin Transplant (2008) 0.75
Neuroanatomical correlates of childhood sexual abuse: identifying biological substrates for environmental effects on clinical phenotypes. Am J Psychiatry (2013) 0.75
Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Transplantation (2012) 0.75
Health Disparities in Kidney Transplantation for African Americans. Am J Nephrol (2017) 0.75
Randomized clinical trial of two oral care regimens in reducing and controlling established dental plaque and gingivitis. Am J Dent (2015) 0.75
Rapid correction of severe hyponatremia after computed tomography with intravenous contrast. Mayo Clin Proc (2007) 0.75
Efficacy of two fluoride-free, alcohol-free mouthwashes containing 0.075% or 0.07% CPC in controlling established dental plaque and gingivitis over a 6-week period on adults in Puerto Rico. Am J Dent (2015) 0.75